Daily Archives: April 2, 2019

Combination of first-in-class NBTXR3, radiotherapy, and anti-PD-1 immunotherapy demonstrate efficacy in treating resistant pre-clinical in vivo models of lung cancer

Data presented at AACR Annual Meeting 2019

  • In vivo study conducted alone or in collaboration with The University of Texas MD Anderson Cancer Center demonstrated:
    • NBTXR3 in combination with a PD-1 inhibitor enhanced an abscopal

Organisations should prioritise risk function’s digital fitness to make smarter decisions

LONDON, April 02, 2019 (GLOBE NEWSWIRE) — Organisations should focus on developing stronger digital skills and capacity in their risk function in order to make more informed decisions about risk in a technology-driven world, according …

Organisations should prioritise risk function’s digital fitness to make smarter decisions

LONDON, April 02, 2019 (GLOBE NEWSWIRE) — Organisations should focus on developing stronger digital skills and capacity in their risk function in order to make more informed decisions about risk in a technology-driven world, according …

Chaineum acts as STO Advisor for Carthagea

Chaineum, a France-based corporate finance advisory firm and a pioneering Initial Coin Offering (“ICO”) advisor, accompanies the first French law governed “Security Token Offering” (“STO”) on behalf of its client Carthagea.

A STO is a

Philips presents results from 3-year telehealth program impacting over 100,000 patients across Europe

April 2, 2019

  • Advancing Care Coordination & Telehealth Deployment at Scale (ACT@Scale) Handbook now available to implement and grow population health management to improve patient care and reduce costs in an aging society
  • Analysis from